B2M and COVID-19: Further to these ligands, we also noted increased expression of EREG, OSM, B2M, as well as type II HLA molecules HLA-A, HLA-B, HLA-C, and HLA-E predominantly in CD4+ and CD8+ T cells and monocytes in patients with severe COVID-19.